Works in Hematological Oncology, 2023, Vol 41, Issue 3

Results: 39
    1

    Long‐term outcomes in Hodgkin lymphoma survivors. Temporary trends and comparison with general population.

    Published in:
    Hematological Oncology, 2023, v. 41, n. 3, p. 407, doi. 10.1002/hon.3131
    By:
    • Núñez‐García, Beatriz;
    • Clemente, Mariola Blanco;
    • Sánchez, Juan Cristóbal;
    • Royuela, Ana;
    • Ibargüen, Blanca Cantos Sánchez de;
    • Méndez, Miriam;
    • López‐Ibor, Jorge V.;
    • Martínez, Marta;
    • Traseira, Cristina;
    • Garitaonaindia, Yago;
    • Aguado, Ramón;
    • Calvo, Virginia;
    • Torrente, María;
    • Parejo, Consuelo;
    • Provencio, Zaida;
    • Provencio, Mariano
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8

    COVID‐19 vaccination: Evaluation of humoral and cellular immunity after the booster dose in chronic lymphocytic leukemia patients.

    Published in:
    Hematological Oncology, 2023, v. 41, n. 3, p. 559, doi. 10.1002/hon.3121
    By:
    • Del Poeta, Giovanni;
    • Laureana, Roberta;
    • Bomben, Riccardo;
    • Rossi, Francesca Maria;
    • Pozzo, Federico;
    • Zaina, Eva;
    • Cattarossi, Ilaria;
    • Varaschin, Paola;
    • Nanni, Paola;
    • Boschian Boschin, Romina;
    • Nunzi, Andrea;
    • Postorino, Massimiliano;
    • Pasqualone, Gianmario;
    • Brisotto, Giulia;
    • Steffan, Agostino;
    • Muraro, Elena;
    • Zucchetto, Antonella;
    • Del Principe, Maria Ilaria;
    • Gattei, Valter
    Publication type:
    Article
    9
    10

    Safety and efficacy of SARS‐Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR‐T cell infusion.

    Published in:
    Hematological Oncology, 2023, v. 41, n. 3, p. 563, doi. 10.1002/hon.3119
    By:
    • Metafuni, Elisabetta;
    • Cingolani, Antonella;
    • Fantoni, Massimo;
    • Chiusolo, Patrizia;
    • Giammarco, Sabrina;
    • Sorà, Federica;
    • Galli, Eugenio;
    • Hohaus, Stefan;
    • D'Alò, Francesco;
    • Bellesi, Silvia;
    • Maiolo, Elena;
    • Alma, Eleonora;
    • Laurenti, Luca;
    • Innocenti, Idanna;
    • Autore, Francesco;
    • Limongiello, Maria Assunta;
    • Santangelo, Rosaria;
    • Marchetti, Simona;
    • Ricci, Rosalba;
    • Sica, Simona
    Publication type:
    Article
    11
    12

    Predictive value on advance hodgkin lymphoma treatment outcome of end‐of treatment FDG PET/CT in the HD0607 clinical trial.

    Published in:
    Hematological Oncology, 2023, v. 41, n. 3, p. 415, doi. 10.1002/hon.3117
    By:
    • Biggi, Alberto;
    • Chauvie, Stephane;
    • Fallanca, Federico;
    • Guerra, Luca;
    • Bergesio, Fabrizio;
    • Menga, Massimo;
    • Bianchi, Andrea;
    • Gregianin, Michele;
    • Chiaravalloti, Agostino;
    • Schillaci, Orazio;
    • Pavoni, Chiara;
    • Patti, Caterina;
    • Picardi, Marco;
    • Romano, Alessandra;
    • Schiavotto, Corrado;
    • Sorasio, Roberto;
    • Viviani, Simonetta;
    • La Nasa, Giorgio;
    • Trentin, Livio;
    • Rambaldi, Alessandro
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20

    Distinct genetic landscapes and their clinical implications in younger and older patients with myelodysplastic syndromes.

    Published in:
    Hematological Oncology, 2023, v. 41, n. 3, p. 463, doi. 10.1002/hon.3109
    By:
    • Lee, Wan‐Hsuan;
    • Lin, Chien‐Chin;
    • Wang, Yu‐Hung;
    • Yao, Chi‐Yuan;
    • Kuo, Yuan‐Yeh;
    • Tseng, Mei‐Hsuan;
    • Peng, Yen‐Ling;
    • Hsu, Cheng‐An;
    • Sun, Hsun‐I;
    • Chuang, Yi‐Kuang;
    • Hsu, Chia‐Lang;
    • Tien, Feng‐Ming;
    • Tsai, Cheng‐Hong;
    • Chou, Wen‐Chien;
    • Hou, Hsin‐An;
    • Tien, Hwei‐Fang
    Publication type:
    Article
    21
    22
    23

    Richter transformation in Chronic Lymphocytic Leukemia.

    Published in:
    Hematological Oncology, 2023, v. 41, n. 3, p. 293, doi. 10.1002/hon.3106
    By:
    • Innocenti, Idanna;
    • Benintende, Giulia;
    • Tomasso, Annamaria;
    • Fresa, Alberto;
    • Autore, Francesco;
    • Larocca, Luigi Maria;
    • Laurenti, Luca
    Publication type:
    Article
    24

    Anti‐CD38 antibody isatuximab monotherapy for Japanese individuals with relapsed/refractory multiple myeloma: An update of the phase 1/2 ISLANDs study.

    Published in:
    Hematological Oncology, 2023, v. 41, n. 3, p. 442, doi. 10.1002/hon.3105
    By:
    • Sunami, Kazutaka;
    • Fuchida, Shin‐ichi;
    • Suzuki, Kenshi;
    • Ri, Masaki;
    • Matsumoto, Morio;
    • Shimazaki, Chihiro;
    • Asaoku, Hideki;
    • Shibayama, Hirohiko;
    • Ishizawa, Kenichi;
    • Takamatsu, Hiroyuki;
    • Ikeda, Takashi;
    • Maruyama, Dai;
    • Imada, Kazunori;
    • Uchiyama, Michihiro;
    • Kiguchi, Toru;
    • Iyama, Satoshi;
    • Murakami, Hirokazu;
    • Onishi, Reiko;
    • Tada, Keisuke;
    • Iida, Shinsuke
    Publication type:
    Article
    25

    The impact of CD56 expression in smoldering myeloma patients on early progression.

    Published in:
    Hematological Oncology, 2023, v. 41, n. 3, p. 587, doi. 10.1002/hon.3104
    By:
    • Notarfranchi, Laura;
    • Segreto, Roberta;
    • Vescovini, Rosanna;
    • Dalla Palma, Anna Benedetta;
    • Marchica, Valentina;
    • Burroughs‐Garcia, Jessica;
    • Toscani, Denise;
    • Todaro, Giannalisa;
    • Raimondi, Vincenzo;
    • Iannozzi, Nicolas Thomas;
    • Bonomini, Sabrina;
    • Sammarelli, Gabriella;
    • Craviotto, Luisa;
    • Pedrazzoni, Mario;
    • Storti, Paola;
    • Giuliani, Nicola
    Publication type:
    Article
    26

    Prognostic impact of the UK Myeloma Research Alliance Risk Profile in transplant‐ineligible patients with multiple myeloma who received a melphalan, prednisolone, and bortezomib regimen: A supplementary analysis of JCOG1105.

    Published in:
    Hematological Oncology, 2023, v. 41, n. 3, p. 590, doi. 10.1002/hon.3103
    By:
    • Suzuki, Tomotaka;
    • Maruyama, Dai;
    • Machida, Ryunosuke;
    • Kataoka, Tomoko;
    • Fukushima, Noriyasu;
    • Takayama, Nobuyuki;
    • Ohba, Rie;
    • Omachi, Ken;
    • Imaizumi, Yoshitaka;
    • Tokunaga, Masahito;
    • Katsuya, Hiroo;
    • Yoshida, Isao;
    • Sunami, Kazutaka;
    • Kurosawa, Mitsutoshi;
    • Kubota, Nobuko;
    • Morimoto, Hiroaki;
    • Kobayashi, Miki;
    • Yamamoto, Kazuhito;
    • Kameoka, Yoshihiro;
    • Kagami, Yoshitoyo
    Publication type:
    Article
    27
    28

    Risk factors for fatal cardiac complications after allogeneic hematopoietic cell transplantation: Japanese Society for Transplantation and Cellular Therapy transplant complications working group.

    Published in:
    Hematological Oncology, 2023, v. 41, n. 3, p. 535, doi. 10.1002/hon.3101
    By:
    • Yanagisawa, Ryu;
    • Tamaki, Masaharu;
    • Tanoshima, Reo;
    • Misaki, Yukiko;
    • Uchida, Naoyuki;
    • Koi, Satoshi;
    • Tanaka, Takashi;
    • Ozawa, Yukiyasu;
    • Matsuo, Yayoi;
    • Tanaka, Masatsugu;
    • Ikegame, Kazuhiro;
    • Katayama, Yuta;
    • Matsuoka, Ken‐ichi;
    • Ara, Takahide;
    • Kanda, Yoshinobu;
    • Matsumoto, Kimikazu;
    • Fukuda, Takahiro;
    • Atsuta, Yoshiko;
    • Kato, Motohiro;
    • Nakasone, Hideki
    Publication type:
    Article
    29
    30
    31
    32
    33

    Molecular remission is an independent predictor of progression‐free survival in patients with Waldenström macroglobulinemia treated with chemo‐immunotherapy: Results from the FIL_BIOWM study.

    Published in:
    Hematological Oncology, 2023, v. 41, n. 3, p. 574, doi. 10.1002/hon.3082
    By:
    • Varettoni, Marzia;
    • Zibellini, Silvia;
    • Merli, Michele;
    • Drandi, Daniela;
    • Jiménez, Cristina;
    • Furlan, Daniela;
    • Ferretti, Virginia Valeria;
    • Fabbri, Nicole;
    • Dogliotti, Irene;
    • Varraso, Chiara;
    • Ferrante, Martina;
    • Cappello, Emilia;
    • Peri, Veronica;
    • Cavalloni, Chiara;
    • Borriero, Michela;
    • Facchetti, Giulia Vittoria;
    • Ferrero, Simone;
    • Arcaini, Luca;
    • Garcia‐Sanz, Ramon
    Publication type:
    Article
    34

    Long‐term benefit of IGHV mutated patients in a real‐life multicenter cohort of FCR‐treated chronic lymphocytic leukemia.

    Published in:
    Hematological Oncology, 2023, v. 41, n. 3, p. 567, doi. 10.1002/hon.3080
    By:
    • Moia, Riccardo;
    • Dondolin, Riccardo;
    • De Propris, Maria Stefania;
    • Talotta, Donatella;
    • Mouhssine, Samir;
    • Perutelli, Francesca;
    • Reda, Gianluigi;
    • Mattiello, Veronica;
    • Rigolin, Gian Matteo;
    • Motta, Marina;
    • Olivieri, Jacopo;
    • Fanin, Renato;
    • Perbellini, Omar;
    • Ferrarini, Isacco;
    • Mauro, Francesca Romana;
    • Del Giudice, Ilaria;
    • Laurenti, Luca;
    • Tomasso, Annamaria;
    • Gentile, Massimo;
    • Frustaci, Anna Maria
    Publication type:
    Article
    35
    36
    37
    38

    Issue Information.

    Published in:
    Hematological Oncology, 2023, v. 41, n. 3, p. 291, doi. 10.1002/hon.3020
    Publication type:
    Article
    39

    Correspondence in reference to the previously published manuscript: Reduction of cycles of bendamustine plus rituximab therapy in the cases with good response for indolent B‐cell lymphomas.

    Published in:
    Hematological Oncology, 2023, v. 41, n. 3, p. 571, doi. 10.1002/hon.2989
    By:
    • Autore, Francesco;
    • Fresa, Alberto;
    • Innocenti, Idanna;
    • Principe, Maria Ilaria Del;
    • Maglione, Raffaele;
    • Stefanizzi, Caterina;
    • Pelliccia, Sabrina;
    • Romeo, Azzurra;
    • Cimino, Giuseppe;
    • Papa, Elena;
    • Padua, Laura De;
    • Andriani, Alessandro;
    • Mengarelli, Andrea;
    • Tafuri, Agostino;
    • Ditto, Concetta;
    • Mauro, Francesca Romana;
    • Del Poeta, Giovanni;
    • Laurenti, Luca
    Publication type:
    Article